11α-O-Actety-12β-O-tigloyl Tenacissoside A

Cat. No.: HY-N13158 Pureza: 97.26%: Ficha de datos
COA

SDS
Instrucciones de manejo
FAQs
Technical Support

11α-O-Acetyl-12β-O-tigloyl Tenacissoside A is a polyoxypregnane glycoside derived from Marsdenia tenacissima with anti-cancer activity.

Para uso exclusivo en investigación. No vendemos a pacientes.

11α-O-Actety-12β-O-tigloyl Tenacissoside A Estructura química

No. CAS : 1070901-03-9

Tamaño	Stock	Cantidad
1 mg	En stock	Estimated Time of Arrival: December 31
5 mg	Obtener un presupuesto	Estimated Time of Arrival: December 31
10 mg	Obtener un presupuesto
50 mg	Obtener un presupuesto

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Recomendaciones destacadas

•Related Small Molecules:

•Related Proteins:

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn

11α-O-Acetyl-12β-O-tigloyl Tenacissoside A is a polyoxypregnane glycoside derived from Marsdenia tenacissima with anti-cancer activity^[1]^[2].

Peso molecular

955.09

Fòrmula

C₄₈H₇₄O₁₉

No. CAS

1070901-03-9

Appearance

Solid

Color

White to off-white

SMILES

C[C@@]12[C@]3(CC[C@H]2C(C)=O)[C@@]4(O3)[C@]([C@@]5([C@@](C[C@H](CC5)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O[C@H]7[C@@H]([C@@H]([C@@H]([C@H](O7)C)O[C@@H]8O[C@@H]([C@H]([C@@H]([C@H]8O)O)O)CO)OC)O)OC)([H])CC4)C)([H])[C@@H]([C@H]1OC(/C(C)=C/C)=O)OC(C)=O

Structure Classification

Steroids

Initial Source

Envío

Room temperature in continental US; may vary elsewhere.

Almacenamiento

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Pureza y Documentación

Purity: 97.26%

Select Batch:

Ficha de datos (272 KB) SDS (252 KB)

COA (259 KB)

Instrucciones de manejo (2659 KB)

Referencias

[1]. Chen J, et al. Identification of polyoxypregnane glycosides from the stems of Marsdenia tenacissima by high-performance liquid chromatography/tandem mass spectrometry[J]. Talanta, 2008, 77(1): 152-159. [Content Brief]

[2]. Hu YJ, et al. Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells. J Nat Prod. [Content Brief]